Milestones  
1996
Set up Desano.
 
1998
Set up R&D team to research and develop APIs of ARVs, oncology and steroids.
 
2000
Formulations of ARV generic drugs were developed.
 
2001
APIs and Formulations were manufactured and commercialized.
 
2002
ARV generic drugs manufactured obtained market authorization in China.
 
2003
Two Subsidiary pharmaceutical companies got GMP certificate to become one of the first domestic supplier of ARV generic drugs in China.
 
2004
Set up overseas branches to introduce Desano's brand internationally.
 
2005
R&D Center is honored to be Shanghai Enterprise Technology Center.
 
2006
ARV APIs production site achieved WHO Pre-qualification.
 
2007
New manufacturing sites of APIs and FPPs are established and started to run